Waters Corporation (WAT) Shares Fall 14.5% Following FY2026 Guidance Despite Q4 Beat
Waters Corporation (WAT) shares dropped 14.49% to $326.04 in early trading on Tuesday after the life sciences company issued 2026...
ADVERTISEMENT
Healthcare
Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears
Anavex Life Sciences Corp. (NASDAQ: AVXL) continues advancing its innovative CNS pipeline. Anavex Q1 2026 earnings revealed cash position surging...
BD Posts Solid Q1 Fiscal 2026 Results Ahead of Major Business Pivot
BD (Becton, Dickinson and Company) (NYSE: BDX) reported first-quarter fiscal 2026 results on February 9, 2026, with revenue of $5.3...
Eli Lilly and Company (LLY) to acquire Orna Therapeutics
Eli Lilly and Company (NYSE: LLY) on Monday said it signed an agreement to acquire Orna Therapeutics, Inc., a biotechnology...
Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15%
Medical technology company Becton, Dickinson and Company (NYSE: BDX) reported a decline in adjusted earnings for the first quarter of...
Biogen Shares Rise on Q4 Earnings Beat Despite Lower Revenue Outlook
Shares of Biogen Inc (BIIB) rose 8.53% to $201.18 at close on Friday following the release of fourth-quarter and full-year...
Immunovant Inc (IMVT) Shares Surge 12.4% on Q3 Earnings Beat, Pipeline Milestones
Shares of Immunovant Inc (IMVT) Stock trading near the high end of its 52-week range Shares of Immunovant Inc (IMVT)...
Centene shares slide after fourth-quarter loss and elevated medical costs
Centene Corporation (NYSE: CNC) closed at $39.92, down 2.54% on the day, after reporting fourth-quarter and full-year 2025 results. The...
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance
Encompass Health Corporation (NYSE: EHC) reported its financial results for the fourth quarter and full year ended December 31, 2025,...
Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7%
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported lower revenues and adjusted earnings for the fourth quarter of fiscal 2025. The...